HSPB1 and glioma: 3) Suppressing HSP27 decreases tumor cell survival in all gliomas (Figures 2, 5, 9), but is more effective in SPARC-expressing tumor cells due to the removal of HSP27 inhibition of SPARC-induced pro-apoptotic signaling (Figures 3, 5, 9).